Drug Pipeline

Tumor Infiltrating Lymphocytes (TIL) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-05 NCT07628894 Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03467516 Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma Uveal Neoplasms Active, Not Recruiting
NCT03801083 Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers Biliary Tract Cancer Active, Not Recruiting
NCT03935893 Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers Gastric Cancer Active, Not Recruiting
Phase 1
NCT07628894 Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma… Advanced Cutaneous Melanoma Not Yet Recruiting
Sponsors Running Tumor Infiltrating Lymphocytes (TIL) Trials
Udai Kammula (3) City of Hope Medical Center (1)
Disease Areas
Melanoma (2) Cholangiocarcinoma (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Sarcoma (1) Mesothelioma (1)
Get alerts when Tumor Infiltrating Lymphocytes (TIL) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free